Cytosar-u and Acute kidney failure - a phase IV clinical study of FDA data

Summary:

Acute kidney failure is reported as a side effect among people who take Cytosar-u (cytarabine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Idamycin, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Acute kidney failure when taking Cytosar-u. It is created by eHealthMe based on reports of 585 people who have side effects when taking Cytosar-u from the FDA, and is updated regularly.

What is Cytosar-u?

Cytosar-u has active ingredients of cytarabine. eHealthMe is studying from 586 Cytosar-u users. Check the latest studies of Cytosar-u.

What is Acute kidney failure?

Acute kidney failure is found to be associated with 2,837 drugs and 4,496 conditions by eHealthMe. Check the latest studies of Acute kidney failure.

On Jul, 16, 2026

585 people reported to have side effects when taking Cytosar-u.
Among them, 34 people (5.81%) have Acute kidney failure.

Could Cytosar-u cause Acute kidney failure?

Among these 34 people:

How long have people been on Cytosar-u when they have Acute kidney failure? *

What is the gender of people who have Acute kidney failure when taking Cytosar-u? *

female: 42.42 %
male: 57.58 %

What is the age of people who have Acute kidney failure when taking Cytosar-u? *

What are other drugs people take besides Cytosar-u? *

What are other side effects people have besides Acute kidney failure? *

Fever: 9 people, 26.47%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 8 people, 23.53%
Tumor Lysis Syndrome: 7 people, 20.59%
Multi-Organ Failure (multisystem organ failure): 6 people, 17.65%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 5 people, 14.71%
Liver Function Tests Nos Abnormal: 4 people, 11.76%
Thrombocytopenia (decrease of platelets in blood): 4 people, 11.76%
Cerebellar Syndrome (impaired blood circulation to cerebellum due to lesion in artery): 4 people, 11.76%
Hypotension (abnormally low blood pressure): 4 people, 11.76%
Blood Creatinine Increased: 4 people, 11.76%

What are the existing conditions these people have? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 5.88%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 5.88%
Pain: 1 person, 2.94%
Oedema (fluid collection in tissue): 1 person, 2.94%
Nausea And Vomiting: 1 person, 2.94%
Nausea (feeling of having an urge to vomit): 1 person, 2.94%
Lymphoma (cancer that begins in immune system cells): 1 person, 2.94%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 2.94%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 2.94%
Accidental Exposure: 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Cytosar-u and have Acute kidney failure?

- Check whether Acute kidney failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytosar-u:

Cytosar-u (586 reports)

Browse all side effects of Cytosar-u:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acute kidney failure:

Acute kidney failure (2,837 drugs)

Browse all the conditions that are associated with Acute kidney failure:

Acute kidney failure (4,496 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytosar-u) and Cytosar-u (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.